MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Abiraterone Sandoz | |
New | APOHealth Children's Antihistamine | |
New | Atorvastatin-WGR | |
New | Candesartan HCTZ-WGR | |
New | Carvedilol-WGR | |
New | Celecoxib-WGR | |
New | Ciclosporin-WGR | |
New | Concerta (Switzerland) | |
New | Desven | |
New | Desvenlafaxine-WGR XR | |
New | Diclofenac-WGR | |
New | Dutasteride/Tamsulosin Lupin 500/400 | |
New | Dutasteride/Tamsulosin Sandoz 500/400 | |
New | Exemestane-WGR | |
New | Famciclovir-WGR | |
New | Fintepla | |
New | Instillagel Lido | |
New | Klarvanta | |
New | Metformin Sandoz XR | |
New | Metrol-XL | |
New | Nab-Paclitaxel Juno | |
New | Panadol Rapid Caplets (Reformulation) | |
New | Perindopril Indapamide-WGR | |
New | Perindopril-WGR | |
New | Prazosin Hydrochloride Capsules, USP (Novitium Pharma, USA) (Medsurge) | |
New | Propranolol-WGR | |
New | Rocuronium Baxter | |
New | Rosuvastatin-WGR | |
New | Tenofovir/Emtricitabine 300/200 APX | |
New | Terbinafine-WGR | |
New | Ticalor | |
New | Verdye | |
New | Xobet Cream | |
New | Xobet Ointment | |
New | Zyprexa IntraMuscular (USA) | |
Reinstated | Rabeprazole Mylan | |
Revised | Afluria Quad | Qualitative and Quantitative Composition |
Revised | Antroquoril | TGA Date |
Revised | APO-Baclofen | Adverse Effects (Undesirable Effects), Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | APO-Ciprofloxacin | Boxed Warnings, Special Warnings and Precautions for Use |
Revised | APO-Donepezil | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APOHealth Promethazine Allergy Relief | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Overdose, Special Warnings and Precautions for Use |
Revised | APO-Leflunomide | Product Name change, Special Warnings and Precautions for Use |
Revised | APO-Norfloxacin | Boxed Warnings, Special Warnings and Precautions for Use |
Revised | APO-Olmesartan/Amlodipine (was Olmesartan/Amlodipine APOTEX) | Overdose |
Revised | APO-Olmesartan/Amlodipine/HCTZ | Overdose |
Revised | APX-Amlodipine | Overdose |
Revised | Arcoxia | TGA Date |
Revised | Aridon APN | Adverse Effects (Undesirable Effects) |
Revised | Aspalgin | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, New contraindication, Special Warnings and Precautions for Use |
Revised | Atorvachol | Adverse Effects (Undesirable Effects) |
Revised | Avloire | Dose and Method of Administration, Fertility, Pregnancy and Lactation, New contraindication |
Revised | Azacitidine Eugia | Adverse Effects (Undesirable Effects) |
Revised | Bavencio | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Bimatoprost Sandoz | TGA Date |
Revised | Blincyto | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Blooms the Chemist Atorvastatin | Adverse Effects (Undesirable Effects) |
Revised | Blooms the Chemist Promethazine Allergy Relief | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Overdose, Special Warnings and Precautions for Use |
Revised | BTC Ezetimibe | Special Warnings and Precautions for Use |
Revised | Cabenuva | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties |
Revised | Carbamazepine Sandoz | Dose and Method of Administration, Fertility, Pregnancy and Lactation, New contraindication |
Revised | Celestone Chronodose | TGA Date |
Revised | Celestone-M | TGA Date |
Revised | Chemists' Own Antihistamine for Allergy Relief | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Overdose, Special Warnings and Precautions for Use |
Revised | Chemists' Own Heartburn Relief Pantoprazole | New Brand of Product already available, Sponsor |
Revised | Cholstat | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Cipla Ambrisentan | Qualitative and Quantitative Composition |
Revised | Ciprol | Boxed Warnings, Special Warnings and Precautions for Use |
Revised | Cozaar | TGA Date |
Revised | Cymevene | TGA Date |
Revised | Cystagon | TGA Date |
Revised | DBL Fentanyl Injection | Adverse Effects (Undesirable Effects) |
Revised | Denpax | Adverse Effects (Undesirable Effects) |
Revised | Dilantin | Nature and Contents of Container, Pharmaceutical Form |
Revised | Diphereline | New contraindication |
Revised | Diprivan | Adverse Effects (Undesirable Effects) |
Revised | Diprosone OV | TGA Date |
Revised | Dolapril | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Dolased Forte | Special Warnings and Precautions for Use |
Revised | Dopamine Juno | TGA Date |
Revised | Dovato 50/300 | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | Edurant | Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Emexlon | Contraindications, Dose and Method of Administration, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Entyvio | Fertility, Pregnancy and Lactation |
Revised | Epidyolex | Sponsor |
Revised | Epilim | Nature and Contents of Container |
Revised | Esmolol Hydrochloride Medsurge | TGA Date |
Revised | Esomeprazole AN Powder for Injection | TGA Date |
Revised | Esopreze | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Eutroxsig | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Ezetimibe GH | Special Warnings and Precautions for Use |
Revised | Ezetimibe Sandoz | Special Warnings and Precautions for Use |
Revised | Ezetimibe-WGR | Special Warnings and Precautions for Use |
Revised | Fenezine | Adverse Effects (Undesirable Effects), Contraindications, Overdose, Special Warnings and Precautions for Use |
Revised | Fluad Quad | Qualitative and Quantitative Composition |
Revised | Flucelvax Quad | Qualitative and Quantitative Composition |
Revised | Fluconazole-Baxter | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Fludrocortisone Medsurge | TGA Date |
Revised | Fosamax Plus | TGA Date |
Revised | Fresofol 1% MCT/LCT | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Fungilin | Sponsor |
Revised | Fyzant | TGA Date |
Revised | Gelofusine | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Genox | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Glatira | TGA Date |
Revised | Glycoprep Orange | Adverse Effects (Undesirable Effects), Dose and Method of Administration |
Revised | Glycoprep-O Kit | Adverse Effects (Undesirable Effects), Dose and Method of Administration |
Revised | Histaren | Adverse Effects (Undesirable Effects), Contraindications, Overdose, Product Name change, Special Warnings and Precautions for Use |
Revised | Hospira Levetiracetam Concentrate for IV Infusion | Adverse Effects (Undesirable Effects) |
Revised | Hyoscine Butylbromide Medsurge | TGA Date |
Revised | Imbruvica | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Imfinzi | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Imuran | Adverse Effects (Undesirable Effects), Dose and Method of Administration, List of Excipients, Name of Medicine, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Precautions for Disposal, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Inlyta | Adverse Effects (Undesirable Effects) |
Revised | Iscover | TGA Date |
Revised | Istodax | Sponsor |
Revised | Janumet | TGA Date |
Revised | Jorveza | TGA Date |
Revised | Juluca | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Kalixocin | Contraindications, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Klacid | Contraindications, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Konakion MM | TGA Date |
Revised | Konakion MM Paediatric | TGA Date |
Revised | Lacosamide Sandoz | TGA Date |
Revised | Lariam | TGA Date |
Revised | Levetiracetam GH Oral Solution | Adverse Effects (Undesirable Effects) |
Revised | Levetiracetam-GH | Adverse Effects (Undesirable Effects) |
Revised | Levetiracetam-WGR | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation |
Revised | Lioresal | Nature and Contents of Container, Pharmaceutical Form, Special Precautions for Storage |
Revised | Lipex | TGA Date |
Revised | Livial | TGA Date |
Revised | Lukair | Boxed Warnings, Special Warnings and Precautions for Use |
Revised | Medsurge Alfentanil | TGA Date |
Revised | Modafinil GH | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Modafinil Sandoz | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Moximed | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Mytolac | Adverse Effects (Undesirable Effects), Therapeutic Indications |
Revised | Neotigason | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Nexium | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Nexium Hp7 | Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Nexium IV | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Nicotinic Acid | Name of Medicine, Qualitative and Quantitative Composition |
Revised | Nilstat Vaginal | Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Overdose, Pharmaceutical Form, Pharmacological Properties, Physicochemical Properties, Qualitative and Quantitative Composition, Shelf Life, Special Precautions for Disposal, Special Precautions for Storage, Special Warnings and Precautions for Use, Sponsor |
Revised | Olmekar | Overdose, Sponsor |
Revised | Olmetec | TGA Date |
Revised | Olmetec Plus | TGA Date |
Revised | Onureg | Sponsor |
Revised | Oroxine | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Oxaliplatin Accord | Fertility, Pregnancy and Lactation |
Revised | Oxycodone HCl Medsurge | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Oxycodone Juno | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Panadol | Nature and Contents of Container, Sponsor |
Revised | Panadol Osteo | List of Excipients, Nature and Contents of Container |
Revised | Picoprep Orange | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration |
Revised | Picosalax | Adverse Effects (Undesirable Effects) |
Revised | Pomalyst | Sponsor |
Revised | Potassium Chloride Aborns | Nature and Contents of Container, Product Name change, Sponsor |
Revised | Pramin | Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Pravastatin Sandoz | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Predsol Suppository and Retention Enema | Sponsor |
Revised | Prepkit Orange | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New contraindication |
Revised | Prevymis | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, New indication, Overdosage, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Prochlorperazine-WGR | TGA Date |
Revised | Propecia | TGA Date |
Revised | Proscar | TGA Date |
Revised | Pulmoris | Qualitative and Quantitative Composition |
Revised | Rabeprazole Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Retevmo | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Revlimid | Sponsor |
Revised | Riluzole Sandoz | TGA Date |
Revised | Rivotril | Fertility, Pregnancy and Lactation |
Revised | Rizatriptan Wafers-10 mg (Organon) | Pharmaceutical Form |
Revised | Roaccutane | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Robinul | TGA Date |
Revised | Rosalee | TGA Date |
Revised | Rosie | TGA Date |
Revised | Rotarix Oral Liquid | Dose and Method of Administration, Nature and Contents of Container |
Revised | SalplusF Inhaler | Dose and Method of Administration |
Revised | Saxenda | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Serepax | TGA Date |
Revised | Sevikar | TGA Date |
Revised | Sigmaxin | Qualitative and Quantitative Composition, Sponsor |
Revised | Sildatio PHT | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Sildenafil Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Singulair | Boxed Warnings, Deleted Presentation, Special Warnings and Precautions for Use |
Revised | Sofradex | Sponsor |
Revised | Soframycin Ear | Sponsor |
Revised | Soframycin Eye | Sponsor |
Revised | Solu-Cortef | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Spikevax | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Staquis | TGA Date |
Revised | Stelax | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Stilnox | Nature and Contents of Container |
Revised | TachoSil | Sponsor |
Revised | Tadalafil GH | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Tadalafil Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Taltz | Adverse Effects (Undesirable Effects) |
Revised | Tanilone | Special Warnings and Precautions for Use |
Revised | Tegretol | Dose and Method of Administration, Fertility, Pregnancy and Lactation, New contraindication, Special Warnings and Precautions for Use |
Revised | Tenofovir GH | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Tenofovir/Emtricitabine Sandoz 301/200 | TGA Date |
Revised | Thalomid | Sponsor |
Revised | Tivicay | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | Tobramycin Viatris | Special Warnings and Precautions for Use |
Revised | Topamax | Fertility, Pregnancy and Lactation |
Revised | Topiramate-WGR | Fertility, Pregnancy and Lactation |
Revised | Tramedo SR | TGA Date |
Revised | Triumeq | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | Trovas | Adverse Effects (Undesirable Effects) |
Revised | Valcyte | Dose and Method of Administration, Special Precautions for Storage |
Revised | Varivax Refrigerated | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmaceutical Form, Pharmacological Properties |
Revised | Vaxigrip Tetra | Adverse Effects (Undesirable Effects) |
Revised | Velsipity | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Vesanoid | TGA Date |
Revised | Victoza | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Voriconazole InterPharma | Contraindications, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Vzole | Interactions with Other Medicines and Other Forms of Interactions, New contraindication |
Revised | Xyvion | TGA Date |
Revised | Yescarta | Adverse Effects (Undesirable Effects), Boxed Warnings |
Revised | Zantac 150 mg OTC | Presentation |
Revised | Zantac Double Strength | Presentation |
Revised | Zarontin | List of Excipients, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Zavicefta | Special Warnings and Precautions for Use |
Revised | Zeposia | Sponsor |
Revised | Zomig | Sponsor |
Revised | Zostrix | Dosage and Administration, Precautions |
Revised | Zostrix HP | Dosage and Administration, Precautions |
Revised | Zyprexa Relprevv | TGA Date |
Deleted | Activase (Canada) | |
Deleted | APOHealth Anti-inflammatory Pain Relief Tablets | |
Deleted | Cathflo (Canada) | |
Deleted | Cervarix | |
Deleted | Cholestyramine-Odan Powder for Oral Suspension, USP (Odan, Canada) | |
Deleted | Esomeprazole SZ | |
Deleted | Hospira Glycopyrrolate Injection | |
Deleted | Ibupane | |
Deleted | Irbesartan GH | |
Deleted | Ketoral Injection | |
Deleted | Noumed Pregabalin | |
Deleted | Nyxoid (UK) | |
Deleted | Olanzapine ODT Generichealth | |
Deleted | Osmohale (UK) | |
Deleted | Ozempic (Germany) (Cole) | |
Deleted | Ozempic (Germany) (Medsurge) | |
Deleted | Pfizer (Australia) Methotrexate Injection BP | |
Deleted | Primaxin | |
Deleted | Tazopip | |
Deleted | TechneLite Generator | |
Deleted | Toilax (Finland) | |
Deleted | Trulicity (Netherlands) | |
Deleted | Trulicity (Switzerland) | |
Deleted | Zovirax |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 1602, Level 16
44 Market Street
Sydney NSW 2000
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au